A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation

SC Nilsson, D Karpman, F Vaziri-Sani… - Molecular …, 2007 - Elsevier
Factor I (FI) is the major complement inhibitor that degrades C3b and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …
被引用次数：115 相关文章

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.

S Nilsson, D Karpman, FV Sani… - Molecular …, 2007 - portal.research.lu.se
Factor I (FI) is the major complement inhibitor that degrades Ob and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation

SC Nilsson, D Karpman, F Vaziri-Sani… - Molecular …, 2007 - infona.pl
Factor I (FI) is the major complement inhibitor that degrades C3b and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation

SC Nilsson, D Karpman, F Vaziri-Sani… - Molecular …, 2007 - pubmed.ncbi.nlm.nih.gov
Factor I (FI) is the major complement inhibitor that degrades C3b and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation

SC Nilsson, D Karpman, F Vaziri-Sani… - Molecular …, 2007 - diva-portal.org
Factor I (FI) is the major complement inhibitor that degrades C3b and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.

SC Nilsson, D Karpman, F Vaziri-Sani… - Molecular …, 2006 - europepmc.org
Factor I (FI) is the major complement inhibitor that degrades C3b and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.

S Nilsson, D Karpman, F Vaziri Sani… - Molecular …, 2007 - lup.lub.lu.se
Factor I (FI) is the major complement inhibitor that degrades Ob and C4b in the presence of
cofactors such as factor H (FH) and membrane cofactor protein (MCP). Recently, mutations …

[引用][C] A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor i in complement regulation

SC NILSSON, D KARPMAN, F VAZIRI-SANI… - Molecular …, 2007 - Elsevier